tert-butyl (3S,4S)-4-amino-3-hydroxypiperidine-1-carboxylate hemioxalate

Catalog No. :
ACKIBI979
CAS No. :
2940876-06-0
Molecular Formula :
C22H42N4O10
Molecular Weight :
522.60

IUPAC Name:tert-butyl (3S,4S)-4-amino-3-hydroxypiperidine-1-carboxylate hemioxalate

tert-butyl (3S,4S)-4-amino-3-hydroxypiperidine-1-carboxylate hemioxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$270.00Login to see priceInquiryInquiry
250mg95%$448.00Login to see priceInquiryInquiry
500mg95%$638.00Login to see priceInquiryInquiry
1g95%$911.00Login to see priceInquiryInquiry
5g95%$2733.00Login to see priceInquiryInquiry
10g95%$4783.00Login to see priceInquiryInquiry
25g95%$10523.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (3S,4S)-4-amino-3-hydroxypiperidine-1-carboxylate hemioxalate
IUPAC Nametert-butyl (3S,4S)-4-amino-3-hydroxypiperidine-1-carboxylate hemioxalate
MDL No.0
Molecular FormulaC22H42N4O10
Molecular Weight522.60
SMILESCC(C)(C)OC(=O)N1CC[C@H](N)[C@@H](O)C1.CC(C)(C)OC(=O)N1CC[C@H](N)[C@@H](O)C1.O=C(O)C(=O)O
InChI KeyBVRWJBOIRGRSOE-AQHOMMPKSA-N
Synonym(3S,4S)-4-Amino-1-Boc-piperidin-3-ol Hemioxalate;1-Piperidinecarboxylic acid, 4-amino-3-hydroxy-, 1,1-dimethylethyl ester, ethanedioate (2:1), (3S,4S)-;tert-butyl (3S,4S)-4-amino-3-hydroxy-piperidine-1-carboxylate hemi(oxalic acid)
CAS No.2940876-06-0

Synthetic Route by SureRoute

1. ACKIBI979 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIBI979 route product structure diagram
    ACKIBI9792940876-06-0
Inquiry

2. ACKIBI979 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIBI979 route product structure diagram
    ACKIBI9792940876-06-0
Inquiry

Comments (0)